Sell Your Orthopedics Practice in Nevada
Considering an exit from your orthopedics practice in Las Vegas or Henderson? We connect owners with serious, funded buyers — confidentially, with no public listing, and at zero cost to you.
Thinking About Selling Your Orthopedics Practice in Nevada?
If you run a non-surgical orthopedic or musculoskeletal practice — the kind built around physiatry, sports medicine, regenerative and orthobiologic injections, ultrasound-guided procedures, bracing and DME, and conservative spine and joint care — you are sitting in one of the more sought-after corners of physician medicine right now. Buyers like this model precisely because it captures the patient before surgery and keeps them in the system afterward: high-volume, recurring, image-and-procedure-driven care that does not depend on OR block time or a single rainmaker surgeon.
Most owners we talk to are not in distress. They are exploring an exit because the operating reality has shifted — payer contracting and prior-authorization burden keep climbing, in-office ancillaries (imaging, PT, DME, an ASC stake) are expensive to build alone, and the larger ortho and MSK platforms consolidating in their market are starting to set the referral patterns. Selling to a funded, insurance-model buyer is a way to take meaningful chips off the table, hand off the administrative load, and still practice — without ever publicly listing the practice. DealSeam keeps the process confidential and is paid by the buyer, so it costs you nothing to understand what your practice is worth.
What Orthopedics Practices Sell For
Non-surgical orthopedic and MSK practices generally trade on a multiple of earnings, expressed as SDE for owner-operator practices or as EBITDA once the books are normalized to a market salary and an institutional cost structure. In this specialty, SDE multiples typically run about 3.0x to 5.5x and EBITDA multiples roughly 5.0x to 10.0x, with the spread driven largely by provider count and ancillary depth. Larger, multi-provider groups with owned imaging, PT, and procedural capacity tend to sit at the upper end; a single-physician office with limited ancillaries typically sits lower. These are general ranges, and your own number depends on your specifics — treat any estimate as a starting point for a conversation, not a guarantee.
What tends to move you up the range is concentrated in a few levers: owned, in-network ancillaries (imaging, PT, DME, ASC equity) that capture the full episode; a diversified commercial-and-Medicare payer book rather than comp- or PI-heavy revenue; a provider bench that runs volume without you; clean procedural coding and documentation; and durable, diversified referral inflow. What tends to move you down: heavy single-payer or workers' comp/PI concentration, a large cash-pay regenerative line that does not underwrite the same way, owner-dependent volume, soft or expiring payer contracts, and looming capital needs (aging C-arm, ultrasound, or EHR). Two practices with identical collections can be a full turn or more apart on these factors alone.
What's Your Orthopedics Worth?
Get an instant valuation estimate based on industry multiples in Nevada.
Why Buyers Want Orthopedics Practices
Non-surgical orthopedics is a strategic anchor for the larger MSK roll-ups. Platform buyers — orthopedic and physiatry groups, sports-medicine networks, and the PE firms behind them — want the conservative-care front door because it feeds a whole continuum: imaging, physical therapy, injections and orthobiologics, bracing/DME, pain management, and, when they own surgical capacity, downstream ASC and surgical referrals they can keep in-network. A practice that already does in-office MSK ultrasound, fluoroscopy or its own diagnostic imaging, and a PT line is typically more valuable than referrals walking out the door, because the buyer captures margin across the episode rather than just the office visit.
The economics also fit the playbook. These practices generate dependable, insurance-reimbursed visit and procedure volume across commercial, Medicare, and (where contracted) workers' comp — diversified rather than dependent on one elective procedure. Add a deep provider bench (physiatrists, sports-med-trained physicians, NPs and PAs running injection and follow-up clinics) and the revenue is less tied to the selling owner, which is exactly the de-risking a platform underwrites. Buyers often pay up for ancillary depth, clean payer contracts, and a team that stays.
What to Prepare Before You Sell
Map your ancillary stack and who owns it: in-office MSK ultrasound, fluoroscopy/C-arm, X-ray or MRI, an in-house PT line, bracing/DME dispensing, and any ASC or imaging-center equity. Owned ancillaries generally support a higher multiple, because buyers tend to pay most for episodes they can keep in-network rather than refer out.
Document your payer mix and your workers' comp / personal-injury / auto (PIP) share explicitly. A balanced commercial-plus-Medicare book is typically the most fundable. A heavy comp, PI, or lien-based concentration is a poorer fit for insurance-model buyers and tends to compress the multiple, since that revenue is often slower-paying and case-dependent.
Quantify provider depth beyond yourself — physiatrists, sports-medicine physicians, interventional pain colleagues, and the NPs/PAs running injection and follow-up clinics. Buyers underwrite on revenue that survives your departure, so a busy associate bench and a reasonable transition-coverage commitment from you tend to be worth real value.
Get your orthobiologic and regenerative line straight: which injections are billed to insurance versus paid cash (PRP, certain orthobiologics). A large cash-pay regenerative book changes how a buyer values you and tends to draw closer diligence — clean, well-organized records help protect the number. How those services are coded and documented is best handled with your own coding and compliance advisors.
Show your referral engine and surgical relationships. Inbound from primary care, PT, urgent care, and athletic programs, plus your downstream surgical/ASC referral patterns, tell a buyer how durable your volume is. Concentration in one or two referring groups is a risk they will typically price in.
Have your procedure, imaging, and E/M coding and documentation in order — for example ultrasound guidance, joint and spine injections, and incident-to arrangements. MSK procedural coding often draws payer scrutiny, so a clean, well-documented compliance posture (maintained with your own advisors) generally supports your valuation during diligence.
Insurance-Based Practices Are in Demand
The buyers most active in MSK today are building in-network, insurance-based platforms, and a non-surgical orthopedic practice with strong commercial and Medicare contracting is squarely what they are underwriting — credentialed providers, established fee schedules, and predictable reimbursed volume they can scale. This is not a knock on cash-pay or concierge models; it is a fit question. Practices whose revenue leans heavily on workers' comp, personal injury, auto/PIP, or lien-based and cash regenerative care are often harder for these buyers to fund, because that mix tends to be slower-paying, case-dependent, and reimbursed differently. If your book is concentrated there, you can still find the right buyer — the pool is simply narrower, and knowing your payer concentration up front lets us match you to a buyer who actually wants that profile rather than one who will discount for it.
What Increases Your Sale Price
- +Insurance-based, in-network payer mix
- +Ancillary services (imaging, PT, DME, injections)
- +Multiple providers and locations
- +Durable referral network
What Buyers Discount
- -Single-physician dependency
- -Heavy personal-injury / single-payer concentration
- -Out-of-network or cash-pay reliance
- -Surgery-center dependency
The Nevada Market for Orthopedics Practices
Nevada's healthcare landscape is shaped by a population that has grown quickly and continues to age, with demand concentrated in the Las Vegas–Henderson metro and a second hub around Reno-Sparks. That growth, combined with what has historically been a comparatively limited supply of practicing providers across much of the state, has made established, in-network practices in primary care, dental, behavioral health, dermatology, ophthalmology, urgent care, and physical therapy attractive targets for consolidation. Many of these practices remain founder- or partner-owned, which is the kind of fragmented ownership profile that tends to draw acquirer interest.
On the buy side, Nevada sees activity from a mix of strategic platforms expanding their Western U.S. footprint, private-equity-backed groups, and search funds. Today's active, funded buyers generally favor insurance-based, in-network practices with diversified payer mixes; cash-pay or concierge models, and practices heavily concentrated in a single payer (for example, predominantly personal-injury or workers'-comp), tend to be a narrower fit. If your practice is in-network and serves a stable commercial and Medicare patient base in Las Vegas, Henderson, or Reno, you are likely operating in the part of the market where buyer demand is most consistent. DealSeam works confidentially on the seller's side: we connect owners with qualified, funded buyers, the buyer pays the success fee, and nothing is ever publicly listed.
A note on structure: Management-company and MSO-style structures are commonly used in healthcare practice transactions, but how clinical ownership, the corporate-practice-of-medicine doctrine, and any professional-entity requirements apply to your specific practice in Nevada should be confirmed with qualified healthcare counsel before a sale.
Is Now the Right Time to Sell?
The common triggers we see are an owner reaching the back half of their career and wanting to de-risk while still practicing for a few years; a regional ortho, physiatry, or sports-medicine platform consolidating the market and reshaping referral patterns; the realization that the next stage of growth (an MRI suite, an ASC stake, a second location, an EHR replacement) needs capital the practice cannot easily self-fund; partnership or succession changes inside the group; and rising prior-authorization and contracting burden making solo operation less appealing. Any one of these is a reasonable moment to learn what your practice would be worth to a funded buyer.
Start a Confidential ConversationHow Selling Through DealSeam Works
Confidential Conversation
We learn about your orthopedics practice and your goals. No pressure, no obligation, nothing public.
Match to the Right Buyer
We match you to funded buyers actively acquiring orthopedics practices in Nevada — not a public auction.
You Choose
Meet the buyers you want, on your timeline. We advise throughout — and the buyer, not you, covers our fee.
Selling a Orthopedics Practice in Nevada: Common Questions
Does my orthobiologic / regenerative injection revenue (PRP, etc.) help or hurt my valuation?
It depends largely on how it is billed and documented. Insurance-reimbursed procedural volume — guided injections, viscosupplementation, and the like — tends to underwrite cleanly and support your number. A large cash-pay regenerative line is generally valued differently and draws extra diligence, because it does not carry the same payer-contract durability. It is rarely a dealbreaker, but you want the streams clearly separated so a buyer can value each on its own terms; how each is coded and documented is best confirmed with your own advisors.
I refer all my surgeries out — am I still attractive to an orthopedic platform buyer?
Yes, often more so. The conservative-care front door is exactly what many surgical platforms want, because it feeds imaging, PT, injections, and downstream surgical and ASC volume they would otherwise lose to referrals. If a buyer owns surgical capacity, your non-operative practice can become the top of their funnel. The value is in keeping those episodes in-network, not in you performing surgery.
A lot of my volume is workers' comp and personal injury — how does that affect a sale?
It tends to narrow the buyer pool more than it kills a deal. Insurance-model platforms generally prefer a diversified commercial-and-Medicare book, because comp, PI, and PIP revenue is often slower-paying and case-dependent. If that work is a meaningful share of your collections, the practical move is to document it precisely so we can match you to a buyer who specifically wants that profile, rather than letting it surface late in diligence as a discount.
Will I have to keep practicing and treating patients after I sell?
Usually for a defined transition period, yes — and most non-surgical orthopedic owners want to. Because buyers underwrite on revenue that survives your exit, a reasonable continued-coverage and referral-transition commitment from you tends to protect your valuation and smooth the handoff. The structure is negotiable; many owners step back gradually rather than all at once, and a provider bench carrying volume can reduce how long you are needed. Specific deal terms are something to work through with your own legal and financial advisors.
How much is my orthopedics practice in Nevada worth?
Orthopedics practices typically trade around 5x–10x EBITDA (roughly 3x–5.5x SDE for owner-operated practices), with most deals in the $1M - $20M range. Value depends on payer mix, provider depth, ancillary revenue, and how dependent the practice is on you personally. Our free valuation calculator gives you an instant range.
Do I pay anything to work with DealSeam?
No. Sellers pay nothing. We're compensated by the buyer when a deal closes — there's no listing fee, no retainer, and no public listing of your practice.
Will my staff, patients, or competitors find out?
No. The process is completely confidential. We never share your information without your explicit permission, and your practice is never publicly listed on a marketplace.
What kind of buyers do you work with?
Funded private-equity platforms, strategic healthcare groups, and search funds actively acquiring orthopedics practices — including buyers specifically seeking insurance-based practices in Nevada.
I'm not ready to sell yet — is it still worth a conversation?
Yes. Many owners start a confidential conversation one to three years before they exit, to understand what their practice is worth and how to prepare. There's no pressure and no obligation.
Other Practices in Nevada
Ready to Explore Selling Your Orthopedics Practice?
Start with a confidential conversation. No pressure, no obligation, and nothing public — just a clear read on what your Nevada practice is worth and who's buying.
Start a Confidential Conversation